Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 4, 2008
Diabetes Care 31:971-973, 2008
DOI: 10.2337/dc07-1588
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1588v1
31/5/971    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Premaratne, E.
Right arrow Articles by Jerums, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Premaratne, E.
Right arrow Articles by Jerums, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Research

Serial Measurements of Cystatin C Are More Accurate Than Creatinine-Based Methods in Detecting Declining Renal Function in Type 1 Diabetes

Erosha Premaratne, MBBS, FRACP1, Richard J. MacIsaac, PHD, MBBS, FRACP1, Sue Finch, PHD2, Sianna Panagiotopoulos, PHD1, Elif Ekinci, MBBS1 and George Jerums, MBBS, FRACP, MD1

1 Endocrine Centre, Austin Health, University of Melbourne, Melbourne, Australia
2 Statistical Consulting Centre, University of Melbourne, Melbourne, Australia

Corresponding author: Dr. Erosha Premaratne, Endocrine Centre, Austin Health, Studley Road, Heidelberg, Victoria 3084, Australia. E-mail: erosha{at}aanet.com.au

OBJECTIVE—Cystatin C–and creatinine-based methods were compared with 99m-technetium-diethylene-triamine-penta-acetic acid (99mTc-DTPA) plasma clearance (isotopic glomerular filtration rate [iGFR]) for detecting declining renal function.

RESEARCH DESIGN AND METHODS—Glomerular filtration rate (GFR) was monitored over a mean of 10.1 years in 85 subjects with type 1 diabetes (with an average of 5.6 measurements per individual). Baseline mean ± SD iGFR of the cohort was 106.1 ± 2.6 ml/min per 1.73 m2. The rates of decline in GFR ({Delta}GFR) were derived using linear regression.

RESULTS—In 19 of 85 subjects with declining renal function (i.e., {Delta}iGFR >3.3 ml/min per 1.73 m2 per year), {Delta}GFR (ml/min per 1.73 m2 per year) was 6.5 by iGFR, 4.2 by 104/creatinine, 3.6 by Cockcroft-Gault formula, 3.4 by the Modification of Diet in Renal Disease (MDRD)-6 equation, and 3.5 by the MDRD-4 variable equation (P < 0.01 vs. iGFR). In comparison, {Delta}GFR was 6.1 using the formula Cys-GFR = (86.7/cystatin C concentration) – 4.2 (not significant).

CONCLUSIONS—Cystatin C was more accurate in detecting decline in renal function than creatinine-based methods in this population of subjects with type 1 diabetes and a normal mean baseline GFR.

Abbreviations: GFR, glomerular filtration rate • iGFR, isotopic GFR • MDRD, Modification of Diet in Renal Disease • 99mTc-DTPA, 99m-technetium-diethylene-triamine-penta-acetic acid


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.